Want to join the conversation?
In 3Q16, $SNX posted revenue of $3.3Bil in its Technology Solutions segment, up 9.8% from 3Q15. Adjusting for FX translation, Technology Solutions grew by 9% versus last year. In the Concentrix segment, revenue was $406.7MM, up 13.1% from last year. Adjusting for the Minacs acquisition and FX translation, Concentrix revenue grew 5% from last year.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.